CDK2 Cancer Research Results
CDK2, Cyclin-dependent kinase 2: Click to Expand ⟱
| Source: |
| Type: |
(CDK2) complex is significantly over-activated in many cancers.
CDK2 (Cyclin-Dependent Kinase 2) is a serine/threonine kinase that regulates late G1 and S phase of the cell cycle.
CDK2 interacts with and phosphorylates proteins in pathways such as DNA damage, intracellular transport, protein degradation, signal transduction, DNA and RNA metabolism and translation.
|
NA, Not Available: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
E7↓, E6↓, PI3K/Akt↓, P53↑, p27↑, P21↑, CDK2↓, mTOR↓, HIF-1↓, IGF-1↓, EGFR↓, ERK↓, VEGF↓,
| - |
in-vitro, |
PC, |
NA |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
Gli1↓, TumCCA↑, TumCMig↓, TumCI↓, CDK2↓, cycE/CCNE↓, P21↑, p27↑,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
PI3K/Akt↓, 1,
Cell Death ⓘ
p27↑, 2,
DNA Damage & Repair ⓘ
P53↑, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 2, cycE/CCNE↓, 1, P21↑, 2, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, Gli1↓, 1, IGF-1↓, 1, mTOR↓, 1,
Migration ⓘ
TumCI↓, 1, TumCMig↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 1, HIF-1↓, 1, VEGF↓, 1,
Clinical Biomarkers ⓘ
E6↓, 1, E7↓, 1, EGFR↓, 1,
Total Targets: 19
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: CDK2, Cyclin-dependent kinase 2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:467 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page